Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
about
Zinc-finger protein X-linked is a novel predictor of prognosis in patients with colorectal cancer.Gab2 is a novel prognostic factor for colorectal cancer patientsThe Relationship between Telomerase Activity and Clinicopathological Parameters in Colorectal Cancer: A Meta-Analysis.The role of microRNAs in colorectal cancer.Clinicopathological significance of SPC18 in colorectal cancer: SPC18 participates in tumor progression.Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancerAssociation of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma.Targeting Six1 by lentivirus-mediated RNA interference inhibits colorectal cancer cell growth and invasion.Upregulation of TSPAN12 is associated with the colorectal cancer growth and metastasisNon-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.MiR-1260b inhibitor enhances the chemosensitivity of colorectal cancer cells to fluorouracil by targeting PDCD4/IGF1
P2860
Q33898743-06BEC253-9A40-43FC-9A4D-84F2FC9289E0Q35632166-37F796F5-06F4-4130-A869-0A6AE3524B67Q35953585-8C33AA8F-B144-4949-B82A-DBEF0975D11FQ36096641-14414898-9E1A-4433-AD68-351E6D3E9D19Q36196750-827154BE-11D2-472A-98F0-C810A9BC2D6AQ36454371-2A983519-DE01-4E73-A9A2-C4074E03696DQ37350337-4F42689F-F99E-4252-B08E-E877AE53FADFQ37587365-28976DE2-E239-4D7B-A32B-25E438B86D11Q37685314-0E4CC42E-76D2-4551-B8B9-F56571743194Q38826546-F2915268-217B-4EDC-9386-21C7EC90BC6CQ57144441-57337E3B-944A-4B96-A25F-E021F6F7C29A
P2860
Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
@en
Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
@nl
type
label
Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
@en
Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
@nl
prefLabel
Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
@en
Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
@nl
P2860
P356
P1476
Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
@en
P2093
John R Zalcberg
Yu Jo Chua
P2860
P304
P356
10.1586/14737140.8.4.595
P577
2008-04-01T00:00:00Z